Vocinti Description

Concise Prescribing Info Bahasa Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Description

See Table 1.

Click on icon to see table/diagram/image

Each tablet contains 10 mg of vonoprazan (13.36 mg of vonoprazan fumarate) and 20 mg of vonoprazan (26.72 mg of vonoprazan fumarate).
Vonoprazan Fumarate occurs as a white to practically white crystals or crystalline powder. It is soluble in dimethylsulfoxide, sparingly soluble in N,N-dimethylacetamide, slightly soluble in methanol and water and practically insoluble in 2-propanol and acetonitrile.
Nonproprietary name: Vonoprazan Fumarate [JAN].
Chemical name: 1-[5-(2-Fluorophenyl)-l-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanaminemonofumarate.
Molecular formula: C₁₇H₁₆FN₃O₂S·C₄H₄O₄.
Molecular weight: 461.46.
Melting point: 194.8°C.
Excipients/Inactive Ingredients: D-Mannitol, Crystalline Cellulose, Croscarmellose Sodium, Hydroxypropyl Cellulose, Fumaric Acid, Magnesium Stearate, Hypromellose, Macrogol 6000, Titanium Oxide (contained in all products), Yellow Ferric Oxide (contained in VOCINTI 10 mg Tablet only), Iron Sesquioxide (contained in VOCINTI 20 mg Tablet only).

vonoprazan

Manufacturer:

Takeda

Marketer:

Wellesta